EGFR inhibitor


Entry
DG03162                     DGroup                                 
Name
EGFR inhibitor
Type
Target
Member
D01977  
Gefitinib (JP18/USAN/INN)  <JP/US>
DG00711  
Erlotinib
 D07907  
Erlotinib (INN)
 D04023  
Erlotinib hydrochloride (JAN/USAN)  <JP/US>
DG00717  
Afatinib
 D09724  
Afatinib (USAN/INN)
 D09733  
Afatinib dimaleate (USAN); Afatinib maleate (JAN)  <JP/US>
D10766  
Osimertinib mesylate (USAN); Osimertinib mesilate (JAN)  <JP/US>
D10858  
Rociletinib (USAN/INN)
DG02916  
Olmutinib
 D10859  
Olmutinib (USAN/INN)
 D11115  
Olmutinib hydrochloride (USAN)
DG01793  
Dacomitinib
 D09883  
Dacomitinib (INN)
 D10514  
Dacomitinib (USAN); Dacomitinib hydrate (JAN)  <JP/US>
D11251  
Icotinib
D03455  
Cetuximab (USAN/INN); Cetuximab (genetical recombination) (JAN)  <JP/US>
D05350  
Panitumumab (USAN/INN); Panitumumab (genetical recombination) (JAN)  <JP/US>
D10018  
Necitumumab (USAN/INN); Necitumumab (genetical recombination) (JAN)  <JP/US>
D11894  
Amivantamab (USAN/INN); Amivantamab (genetical recombination) (JAN)  <US>
DG03205  
Lazertinib
 D11980  
Lazertinib (USAN)
 D12245  
Lazertinib mesilate hydrate (JAN)
DG03209  
Aumolertinib
 D12258  
Aumolertinib (USAN)
 D12259  
Aumolertinib mesylate (USAN)
 » expand
Class
Antineoplastic
 DG01918  Tyrosine kinase inhibitor
  DG01917  Receptor tyrosine kinase inhibitor
Remark
ATC code: L01EB